Next Article in Journal
Ultrastructural Remodeling of the Neurovascular Unit in the Female Diabetic db/db Model–Part II: Microglia and Mitochondria
Previous Article in Journal
Mediation of FoxO1 in Activated Neuroglia Deficient for Nucleoside Diphosphate Kinase B during Vascular Degeneration
Review

In Search of a Breakthrough Therapy for Glioblastoma Multiforme

1
Institute of Living Systems, Immanuel Kant Baltic Federal University, Universitetskaya str, 2, Kaliningrad 236041, Russia
2
School of Physiology, Pharmacology and Neuroscience, University of Bristol, University Walk, Bristol BS8 1TD, UK
*
Author to whom correspondence should be addressed.
Those authors make equal contributions to this work.
Received: 21 August 2018 / Revised: 14 September 2018 / Accepted: 20 September 2018 / Published: 26 September 2018
Glioblastoma multiforme (GBM) is an extremely malignant type of brain cancer which originates from astrocytes or their precursors. Glioblastoma multiforme cells share some features with astrocytes but are characterized by highly unstable genomes with multiple driver mutations and aberrations. Effective therapies for GBM are lacking and hardly any progress has been made in the last 15 years in terms of improving the outcomes for patients. The lack of new especially targeted anti-GBM medications has prompted scientists in academia around the world to test whether any of the currently approved drugs might be used to fight this devastating disease. This approach is known as repurposing. Dozens of drugs have been reported to have anti-GBM properties in vitro but there is no solid evidence for the clinical efficacy of any of them. Perhaps the most interesting group of those repurposed are tricyclic antidepressants but the mechanism of their action on GBM cells remains obscure. In this brief review we consider various approaches to repurpose drugs for therapy of GBM and highlight their limitations. We also pay special attention to the mitochondria, which appear to be intimately involved in the process of apoptosis and could be a focus of future developments in search of a better treatment for patients suffering from GBM. View Full-Text
Keywords: glioblastoma multiforme; repurposing; tricyclic antidepressants; mitochondria glioblastoma multiforme; repurposing; tricyclic antidepressants; mitochondria
Show Figures

Figure 1

MDPI and ACS Style

Vasilev, A.; Sofi, R.; Tong, L.; Teschemacher, A.G.; Kasparov, S. In Search of a Breakthrough Therapy for Glioblastoma Multiforme. Neuroglia 2018, 1, 292-310. https://0-doi-org.brum.beds.ac.uk/10.3390/neuroglia1020020

AMA Style

Vasilev A, Sofi R, Tong L, Teschemacher AG, Kasparov S. In Search of a Breakthrough Therapy for Glioblastoma Multiforme. Neuroglia. 2018; 1(2):292-310. https://0-doi-org.brum.beds.ac.uk/10.3390/neuroglia1020020

Chicago/Turabian Style

Vasilev, Alex, Roba Sofi, Li Tong, Anja G. Teschemacher, and Sergey Kasparov. 2018. "In Search of a Breakthrough Therapy for Glioblastoma Multiforme" Neuroglia 1, no. 2: 292-310. https://0-doi-org.brum.beds.ac.uk/10.3390/neuroglia1020020

Find Other Styles

Article Access Map by Country/Region

1
Back to TopTop